oHSV2-mGM repolarizes TAMs and cooperates with αPD1 to reprogram the immune microenvironment of residual cancer after radiofrequency ablation
Article in Biomedicine & Pharmacotherapy (July 2024)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Article in Biomedicine & Pharmacotherapy (July 2024)
Article in World Journal of Gastrointestinal Oncology (July 2024)
Article in Advanced Therapeutics (July 2024)